x POMALYST® (pomalidomide) is a thalidomide analogue indicated, in combination with dexamethasone, for adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

See other indications for POMALYST:

This website is intended for U.S. Healthcare Professionals.

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.

Find a specialty pharmacy.

Specialty Pharmacy Locater Icon

List of specialty pharmacies.

POMALYST is only available through a select network of specialty pharmacies due to a restricted distribution program called POMALYST REMS®. These specialty pharmacies help to manage the handling and shipping of POMALYST and may provide additional resources.